Olomouc, Czechia

Miroslav Urbasek

This inventor holds 1 USPTO granted patent. Top assignee: Farmak, A.s.. Active years: 2006.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Miroslav Urbasek: Innovator in Pharmaceutical Chemistry

Introduction

Miroslav Urbasek is a notable inventor based in Olomouc, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of optically pure enantiomers. His work is characterized by a commitment to innovation and precision in chemical processes.

Latest Patents

Miroslav Urbasek holds a patent for a process titled "Process for preparing R- and S-isomers of (R)-5-(2-( (2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide." This patent details a method for preparing optically pure enantiomers of R-(−)tamsulosin and S-(+)tamsulosin by resolving racemic tamsulosin using specific camphor sulfonic acids in various solvent environments. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Miroslav Urbasek is currently employed at Farmak, a.s., where he continues to advance his research and development efforts. His work at the company has allowed him to explore innovative solutions in pharmaceutical formulations and processes.

Collaborations

Throughout his career, Miroslav has collaborated with esteemed colleagues such as Pavel Hradil and Lubomir Kvapil. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Miroslav Urbasek is a distinguished inventor whose contributions to pharmaceutical chemistry are noteworthy. His innovative processes and collaborations reflect his dedication to advancing the field. His work continues to influence the development of effective pharmaceutical solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…